Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?
Critical Reviews in Food Science and Nutrition · 18.05.2024 · 64 (13) · 4155-4178
DOI: 10.1080/10408398.2022.2139222 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Critical Reviews in Food Science and Nutrition, online erschienen am 08.11.2022. Verfasst von Mostafa Vaghari-Tabari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Polyphenols, Inflammatory Bowel Diseases, Curcumin, Catechin. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 199 Literaturangaben.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a long-life disease with periods of recurrence and relief. Oxidative stress plays an important role in the pathogenesis of this disease. Recent years' studies in the field of IBD treatment mostly have focused on targeting cytokines and immune cell trafficking using antibodies and inhibitors, altering the composition of intestinal bacteria in the line of attenuation of inflammation using probiotics and prebiotics, and attenuating oxidative stress through antioxidant supplementation. Studies in animal models of IBD have shown that some polyphenolic compounds including curcumin, quercetin, resveratrol, naringenin, and epigallocatechin-3-gallate can affect almost all of the above aspects and are useful compounds in the treatment of IBD. Clinical studies performed on IBD patients have also confirmed the findings of animal model studies and have shown that supplementation with some of the above-mentioned polyphenolic compounds has positive effects in reducing disease clinical and endoscopic activity, inducing and maintaining remission, and improving quality of life. In this review article, in addition to a detailed reviewing the effects of the above-mentioned polyphenolic compounds on the events involved in the pathogenesis of IBD, the results of these clinical studies will also be reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry and Laboratory Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Food Science and Technology, Faculty of Nutrition Science, Food Science and Technology/National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Science, Tehran, Iran.
- Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Cellular and Molecular Biology Research Center (CMBRC), Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
ORCID-Profile: Durdi Qujeq
Zitieren
APA
Vaghari-Tabari, M., Alemi, F., Zokaei, M., Moein, S., Qujeq, D., Yousefi, B., Farzami, P., & Hosseininasab, S. S. (2024). Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?. Critical Reviews in Food Science and Nutrition, 64(13), 4155-4178. https://doi.org/10.1080/10408398.2022.2139222
Vancouver
Vaghari-Tabari M, Alemi F, Zokaei M, Moein S, Qujeq D, Yousefi B, et al. Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?. Critical Reviews in Food Science and Nutrition. 2024;64(13):4155-4178. doi:10.1080/10408398.2022.2139222
BibTeX
@article{VaghariTabari2024,
author = {Vaghari-Tabari, Mostafa and Alemi, Forough and Zokaei, Maryam and Moein, Soheila and Qujeq, Durdi and Yousefi, Bahman and Farzami, Payam and Hosseininasab, Seyed Soheil},
title = {Polyphenols and inflammatory bowel disease: Natural products with therapeutic effects?},
journal = {Critical Reviews in Food Science and Nutrition},
year = {2024},
volume = {64},
number = {13},
pages = {4155--4178},
doi = {10.1080/10408398.2022.2139222}
}
EUVIMED